Cargando…
Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity
The cross-presenting capacity of dendritic cells (DCs) can be limited by non-specific degradation during endosome maturation. To bypass this limitation, we present in this study a new Accum-based formulation designed to promote endosome-to-cytosol escape. Treatment of primary DCs with Accum linked t...
Autores principales: | Bikorimana, Jean-Pierre, Salame, Natasha, Beaudoin, Simon, Balood, Mohammad, Crosson, Théo, Abusarah, Jamilah, Talbot, Sebastien, Löbenberg, Raimar, Plouffe, Sebastien, Rafei, Moutih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040180/ https://www.ncbi.nlm.nih.gov/pubmed/35492876 http://dx.doi.org/10.1016/j.xcrm.2022.100534 |
Ejemplares similares
-
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2021) -
CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice
por: Abusarah, Jamilah, et al.
Publicado: (2021)